NCATS staff are experts in many translational research disciplines, and the Center offers tools, technologies and in-kind support to help researchers translate basic scientific knowledge into interventions that improve human health.
NCATS staff are experts in many different fields relevant to translational research and science policy, from small molecules to human subjects protections. NCATS also offers a variety of tools and other resources for pre-clinical and clinical investigators.
Learn more about the experts at NCATS, including research/professional interests and recent publications.
NIH and NCATS have developed several tools and resources to help scientists conduct pre-clinical research.
NCATS supports clinical research tools that facilitate trial design, patient recruitment and partnerships for commercialization.
NCATS maintains cross-cutting technologies to support ongoing operation of all NCATS translational research activities.
Christine Colvis joined NCATS in June 2012 as the Center’s director of drug development partnership programs. Her team is best known for leading the Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, which supports pre-clinical and clinical research using investigational drugs provided by pharmaceutical company partners for disease indications not being pursued by the companies. For the program’s pilot phase, Colvis led the implementation of template agreements that shortened the time required to establish a collaboration between an academic institution and a pharmaceutical company, enabling research efforts to get off the ground faster. Read more about Christine Colvis.
